Related references
Note: Only part of the references are listed.Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver
Michael J. Gray et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model
Qian Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway
Matthias John et al.
NATURE (2007)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Christian Wolfrum et al.
NATURE BIOTECHNOLOGY (2007)
Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C
Takanori Yokota et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
David B. Rozema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
Jeremy D. Heidel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Bryan R. Meade et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
Dan Peer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
City initiative: Baby steps to a better future
Ramesh Vidavalur
PLOS MEDICINE (2006)
Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death
Vineet Bhandari et al.
NATURE MEDICINE (2006)
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice:: Safety and efficacy in xenografted aggressive breast cancer
J. -Y. Pille et al.
HUMAN GENE THERAPY (2006)
RNA interference in vitro and in vivo using a chitosan/siRNA nanoparticle system
Kenneth A. Howard et al.
MOLECULAR THERAPY (2006)
Engineering mucosal RNA interference in vivo
Yingjie Zhang et al.
MOLECULAR THERAPY (2006)
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy
Jyotsnabaran Halder et al.
CLINICAL CANCER RESEARCH (2006)
Therapeutic potential of RNA interference against cancer
Fumitaka Takeshita et al.
CANCER SCIENCE (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs
A Aigner
JOURNAL OF BIOTECHNOLOGY (2006)
Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference
Thomas W. Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Dirk Grimm et al.
NATURE (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
J Shen et al.
GENE THERAPY (2006)
An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection
D Palliser et al.
NATURE (2006)
Aptamer mediated siRNA delivery
Ted C. Chu et al.
NUCLEIC ACIDS RESEARCH (2006)
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma
S Hu-Lieskovan et al.
CANCER RESEARCH (2005)
An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons
Miaw-Chyi Luo et al.
MOLECULAR PAIN (2005)
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque
BJ Li et al.
NATURE MEDICINE (2005)
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain
DR Thakker et al.
MOLECULAR PSYCHIATRY (2005)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
EW Song et al.
NATURE BIOTECHNOLOGY (2005)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
Inhibition of respiratory viruses by nasally administered siRNA
V Bitko et al.
NATURE MEDICINE (2005)
Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis
XC Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
siRNA relieves chronic neuropathic pain
G Dorn et al.
NUCLEIC ACIDS RESEARCH (2004)
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference
DR Thakker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics
Y Takei et al.
CANCER RESEARCH (2004)
Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake
Hideo Makimura et al.
BMC NEUROSCIENCE (2002)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)